Team:Groningen/Notebook/Modeling 12June2012

From 2012.igem.org

(Difference between revisions)
m
 
(2 intermediate revisions not shown)
Line 1: Line 1:
{{HeaderGroningen2012}}
{{HeaderGroningen2012}}
 +
<html>
 +
<head>
 +
<style type="text/css">
 +
p.margin{
 +
font-size:12pt;
 +
line-height:12pt;
 +
color:white;
 +
margin-top:0px;
 +
margin-bottom:20px;
 +
margin-left:150px;
 +
margin-right:250px;
 +
}
 +
</style>
 +
</head>
-
Started research into metabolic control analysis (MCA). FBA has limited potential as, (1) it may only indicate a increase or decrease in lycopene production due to the wide range in fluxes, and (2) it would require precise concentration measurements as a starting point. So, MCA may...may...offer a more accurate description of the pathways.
+
<body>
 +
<br>
 +
<br>
 +
<br>
 +
<p class="margin">
 +
Started research into metabolic control analysis (MCA). FBA has limited potential as,  
 +
(1) it may only indicate a increase or decrease in lycopene production due to the wide range in fluxes,  
 +
and (2) it would require precise concentration measurements as a starting point.  
 +
So, MCA may...may...offer a more accurate description of the pathways.
 +
<br>
 +
<A HREF="https://2012.igem.org/Team:Groningen/Notebook"><FONT COLOR=#ff6700>Back to notebook</FONT></A>
 +
</p>
 +
<br>
 +
<br>
 +
</body>
 +
</html>
 +
 
 +
{{Template:SponsorsGroningen2012}}

Latest revision as of 14:33, 26 September 2012







Started research into metabolic control analysis (MCA). FBA has limited potential as, (1) it may only indicate a increase or decrease in lycopene production due to the wide range in fluxes, and (2) it would require precise concentration measurements as a starting point. So, MCA may...may...offer a more accurate description of the pathways.
Back to notebook



Our sponsors:

Retrieved from "http://2012.igem.org/Team:Groningen/Notebook/Modeling_12June2012"